Input to UN Interim Report on Governing AI for Humanity
This document was written by Bradford Saad, with assistance from Andreas Mogensen and Jeff Sebo. Jakob Lohmar provided valuable research assistance. The document benefited from discussion with or feedback from Frankie Andersen-Wood, Adam Bales, Ondrej Bajgar, Thomas Houlden, Jojo Lee, Toby Ord, Teruji Thomas, Elliott Thornley and Eva Vivalt.
Other papers
Estimating long-term treatment effects without long-term outcome data – David Rhys Bernard (Rethink Priorities), Jojo Lee and Victor Yaneng Wang (Global Priorities Institute, University of Oxford)
The surrogate index method allows policymakers to estimate long-run treatment effects before long-run outcomes are observable. We meta-analyse this approach over nine long-run RCTs in development economics, comparing surrogate estimates to estimates from actual long-run RCT outcomes. We introduce the M-lasso algorithm for constructing the surrogate approach’s first-stage predictive model and compare its performance with other surrogate estimation methods. …
Existential Risk and Growth – Philip Trammell (Global Priorities Institute and Department of Economics, University of Oxford) and Leopold Aschenbrenner
Technologies may pose existential risks to civilization. Though accelerating technological development may increase the risk of anthropogenic existential catastrophe per period in the short run, two considerations suggest that a sector-neutral acceleration decreases the risk that such a catastrophe ever occurs. First, acceleration decreases the time spent at each technology level. Second, since a richer society is willing to sacrifice more for safety, optimal policy can yield an “existential risk Kuznets curve”; acceleration…
Meaning, medicine and merit – Andreas Mogensen (Global Priorities Institute, Oxford University)
Given the inevitability of scarcity, should public institutions ration healthcare resources so as to prioritize those who contribute more to society? Intuitively, we may feel that this would be somehow inegalitarian. I argue that the egalitarian objection to prioritizing treatment on the basis of patients’ usefulness to others is best thought…